Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer

被引：0
|
作者：
Franco Moreno, Ana Isabel [1 ]
Cabezon Gutierrez, Luis [2 ]
Garcia Navarro, Maria Jose [1 ]
机构：
[1] Hosp Univ Torrejon, Serv Med Interna, Unidad Enfermedad Tromboembol, Madrid, Spain
[2] Hosp Univ Torrejon, Serv Oncol Med, Madrid, Spain
来源：
MEDICINA CLINICA | 2019年 / 153卷 / 03期
关键词：
MOLECULAR-WEIGHT HEPARIN; LONG-TERM TREATMENT; BLEEDING COMPLICATIONS; SECONDARY PREVENTION; AMERICAN SOCIETY; ACTIVE CANCER; WARFARIN; PROPHYLAXIS; MALIGNANCY; MANAGEMENT;
D O I：
10.1016/j.medcli.2019.01.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：122 / 125
页数：4
相关论文
共 50 条
  • [31] Anticoagulants for the treatment of venous thromboembolism in patients with cancer: A comprehensive systematic review, pairwise and network meta-analysis
    Sidahmed, Shima
    Abdalla, Ahmed
    Kheiri, Babikir
    Bala, Areeg
    Salih, Mohammed
    Bachuwa, Ghassan
    Kafri, Zyad
    Kuderer, Nicole M.
    Lyman, Gary H.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 152
  • [32] Treatment of venous thromboembolism in cancer patients
    Lee, Agnes Y. Y.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (01) : 93 - 101
  • [33] Safety and Efficacy of Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Pediatric Oncology Patients
    Scheuermann, Amanda
    Liegl, Melodee
    Simpson, Pippa
    Branchford, Brian
    Malec, Lynn
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (01) : E65 - E69
  • [34] Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants
    Wharin, Caitlin
    Tagalakis, Vicky
    BLOOD REVIEWS, 2014, 28 (01) : 1 - 8
  • [35] Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis
    Chen, Hailong
    Tao, Rui
    Zhao, Hui
    Jiang, Jianjun
    Yang, Jin
    MEDICINE, 2020, 99 (05) : E19000
  • [36] Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats
    O'Connell, Casey
    Escalante, Carmen P.
    Goldhaber, Samuel Z.
    McBane, Robert
    Connors, Jean M.
    Raskob, Gary E.
    ONCOLOGIST, 2021, 26 (01): : E8 - E16
  • [37] Anticoagulation in the Treatment of Established Venous Thromboembolism in Patients With Cancer
    Lee, Agnes Y. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (29) : 4895 - 4901
  • [38] Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain
    Munoz, Andres
    Gallardo, Enrique
    Agnelli, Giancarlo
    Crespo, Carlos
    Forghani, Monica
    Arumi, Daniel
    Fernandez de Cabo, Susana
    Soto, Javier
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 840 - 847
  • [39] Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants
    Weitz, Jeffrey I.
    Jaffer, Iqbal H.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (09): : 688 - 696
  • [40] Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
    Margaret C. Fang
    Alan S. Go
    Priya A. Prasad
    Jin-Wen Hsu
    Dongjie Fan
    Cecilia Portugal
    Sue Hee Sung
    Kristi Reynolds
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 1101 - 1109
12345